Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
The evolution of synaptic and cognitive capacity: Insights from the nervous system transcriptome of Aplysia.
Proc Natl Acad Sci U S A
; 119(28): e2122301119, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867761
3.
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Oncologist
; 28(5): 425-432, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807743
4.
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
J Natl Compr Canc Netw
; 21(7): 694-704, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433432
5.
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts.
Br J Cancer
; 127(6): 1069-1075, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715632
6.
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).
Future Oncol
; 18(40): 4465-4471, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912078
7.
Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Dig Dis Sci
; 67(7): 3455-3463, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297268
8.
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Invest New Drugs
; 38(5): 1533-1539, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898183
9.
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
Cancer
; 125(13): 2213-2221, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913304
10.
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
J Natl Compr Canc Netw
; 17(4): 302-310, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959462
11.
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
JAMA
; 321(14): 1370-1379, 2019 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30964527
12.
Cheer* in Health Care Practice: What It Excludes and Why It Matters.
Qual Health Res
; 29(13): 1890-1903, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957656
13.
Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the U.S.
Gastric Cancer
; 21(5): 738-744, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29392573
14.
Enhancing the human dimensions of children's neuromuscular care: piloting a methodology for fostering team reflexivity.
Adv Health Sci Educ Theory Pract
; 23(5): 867-889, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797172
15.
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
Cancer
; 123(11): 1979-1988, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192597
16.
Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer.
Oncologist
; 22(8): 925-933, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476943
17.
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
J Natl Compr Canc Netw
; 15(5): 563-573, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476736
18.
A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma.
Invest New Drugs
; 33(1): 128-37, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25248753
19.
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.
Invest New Drugs
; 32(1): 113-22, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568716
20.
Hepatobiliary cancers, version 2.2014.
J Natl Compr Canc Netw
; 12(8): 1152-82, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099447